Brazil has reported its first H5N1 outbreak in commercial poultry, which involves the 2.3.4.4b clade.
When CDC advisers widened their recommendation in 2023, most members were swayed by data, including those for long COVID, showing that no group is at low risk for the virus.
Both the Moderna and Pfizer mRNA vaccines carried the same 15% increased risk of an extended menstrual cycle.
Analysis of hospitalized patients with community-acquired pneumonia links azithromycin to lower mortality and more hospital-free days compared with doxycycline in combination with beta-lactams.
Today a committee overwhelmingly approved the measure, 3 years in the making, which is up for a final vote in the plenary session tomorrow.
In other H5N1 developments, the USDA confirms an outbreak at an Arizona layer farm that has more than 2 million birds.
The outbreak has sickened 26 people in 15 states and is linked to a grower and distributor in Florida.
Georgia reported its fourth case, a resident of the Atlanta area who had traveled internationally.
More than half of participants had lung abnormality imaging at baseline.
Moderna's combination vaccine was intended for adults 50 and older.
Zevtera, an advanced-generation cephalosporin, is available for treating Staphylococcus aureus bacteremia and 2 other types of bacterial infection.
Live virus was rarely transmitted to fingertips from the fomites.
Starting in August, eligible patients can receive shots of 4CMenB, a vaccine for meningococcal B disease that provides moderate cross-protection against gonorrhea.
The chemical compound blocks malaria parasite transmission in mosquitoes without contributing to insecticide resistance.
The ARTIC 2.0 project will expand use of a low-cost, real-time genome sequencing technique used to detect COVID-19 variants to conduct surveillance on a wider variety of pathogens.
A comparative effectiveness study finds that patients treated with laLGPs had similar outcomes as those who received standard-of-care antibiotics.
Runny nose and congestion were negatively associated with moderate to severe illness.
An industry group responds, "Other than clean water, arguably nothing has done more to improve public health than vaccines."
Costs varied across 5 European countries, driven primarily by repeated primary care visits and parental work absences.
The agency told vaccine makers that COVID-19 vaccines used in the US starting in fall 2025 should be based on JN.1 lineage strains, preferably the LP.8.1 strain.
Experts say illnesses don't seem more severe and more studies are needed to further assess the risk of antibody escape.
The 19 low- and middle-income countries experienced 28,000 congenital rubella syndrome cases—78% of the world's cases—in 2023 alone.
This is the first H5N1 human case reported in mainland China since July 2024.
Reports of human H5N1 cases in Cambodia have been on the rise since the end of 2023.
Two novel antibiotic candidates for gonorrhea received funding to advance into clinical trials.
